Spectral AI, Inc. (MDAI)
Stock analysis · NASDAQ · Healthcare · Medical - Specialties
Spectral AI, Inc. (MDAI) is a publicly traded company in the Healthcare sector. Latest price: $1.56. Market cap $50.21M. Trailing PE -4.47. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Spectral AI, Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Valuation
| P/E (TTM) | -4.47× |
|---|---|
| P/S (TTM) | 3.31× |
| P/B | -4.15× |
| PEG | 0.07× |
| P/FCF (TTM) | -3.90× |
| EV / EBITDA | -6.42× |
| EV / Sales | 3.46× |
| Earnings Yield | -20.98% |
| Free Cash Flow Yield | -25.65% |
Fundamentals
| Enterprise Value | $52.48M |
|---|---|
| Revenue (TTM) | $15.16M |
| Net Income (TTM) | -$10.53M |
| Free Cash Flow (TTM) | -$11.36M |
| Net Debt | $2.28M |
| Working Capital | -$2.08M |
| Gross Margin | 41.51% |
| Operating Margin | -79.95% |
| Net Margin | -69.27% |
| Return on Equity | 120.69% |
| Return on Invested Capital | -288.36% |
Peers
Recent News
- Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call
- Spectral AI's DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly
- Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System
- Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the H…
- Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectra…
Related
Browse more tickers: sitemap